Trial Profile
Perturbing the HIV Reservoir With Immune Stimulation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2022
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Pneumococcal vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 03 Aug 2022 Status changed from active, no longer recruiting to completed.
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections
- 26 Apr 2021 Planned End Date changed from 1 Jan 2021 to 1 Jan 2022.